Insights into Stanley Druckenmiller (Trades, Portfolio)'s Second Quarter 2025 Portfolio Adjustments. Warning! GuruFocus has ...

The FDA has approved oral brensocatib (Brinsupri) for adults and children 12+ with non-cystic fibrosis bronchiectasis. As a ...

A fter a whirlwind week of economic data, stocks are taking a chill pill on Friday, ending off the week on a low note. The ...

Argenx stock catapulted into a breakout in late July, rallying on the back of its "blowout" quarter for a single product: ...